nodes	percent_of_prediction	percent_of_DWPC	metapath
Acenocoumarol—VKORC1—coronary artery disease	0.376	0.822	CbGaD
Acenocoumarol—CYP2C19—coronary artery disease	0.0523	0.114	CbGaD
Acenocoumarol—ORM1—Penbutolol—coronary artery disease	0.0418	0.0997	CbGbCtD
Acenocoumarol—ORM1—Pitavastatin—coronary artery disease	0.0365	0.0872	CbGbCtD
Acenocoumarol—ALB—coronary artery disease	0.029	0.0634	CbGaD
Acenocoumarol—ALB—Pitavastatin—coronary artery disease	0.0154	0.0367	CbGbCtD
Acenocoumarol—ALB—Valsartan—coronary artery disease	0.015	0.0357	CbGbCtD
Acenocoumarol—CYP2C9—Fenofibrate—coronary artery disease	0.0137	0.0326	CbGbCtD
Acenocoumarol—CYP2C19—Gemfibrozil—coronary artery disease	0.0131	0.0314	CbGbCtD
Acenocoumarol—CYP1A2—Gemfibrozil—coronary artery disease	0.0121	0.0289	CbGbCtD
Acenocoumarol—CYP2C19—Clopidogrel—coronary artery disease	0.0114	0.0272	CbGbCtD
Acenocoumarol—ALB—Rosuvastatin—coronary artery disease	0.0113	0.027	CbGbCtD
Acenocoumarol—ALB—Acetylsalicylic acid—coronary artery disease	0.011	0.0263	CbGbCtD
Acenocoumarol—CYP2C9—Gemfibrozil—coronary artery disease	0.0109	0.0261	CbGbCtD
Acenocoumarol—ALB—Captopril—coronary artery disease	0.0109	0.026	CbGbCtD
Acenocoumarol—CYP1A2—Clopidogrel—coronary artery disease	0.0105	0.0251	CbGbCtD
Acenocoumarol—CYP2C19—Telmisartan—coronary artery disease	0.00996	0.0238	CbGbCtD
Acenocoumarol—CYP2C9—Clopidogrel—coronary artery disease	0.00948	0.0226	CbGbCtD
Acenocoumarol—CYP3A4—Ticagrelor—coronary artery disease	0.00892	0.0213	CbGbCtD
Acenocoumarol—ALB—Furosemide—coronary artery disease	0.00877	0.0209	CbGbCtD
Acenocoumarol—ALB—Losartan—coronary artery disease	0.00859	0.0205	CbGbCtD
Acenocoumarol—CYP2C9—Pitavastatin—coronary artery disease	0.00828	0.0198	CbGbCtD
Acenocoumarol—CYP2C9—Valsartan—coronary artery disease	0.00806	0.0192	CbGbCtD
Acenocoumarol—CYP2C19—Timolol—coronary artery disease	0.00803	0.0192	CbGbCtD
Acenocoumarol—CYP3A4—Fenofibrate—coronary artery disease	0.00795	0.019	CbGbCtD
Acenocoumarol—CYP2C19—Rosuvastatin—coronary artery disease	0.00735	0.0175	CbGbCtD
Acenocoumarol—CYP2C19—Acetylsalicylic acid—coronary artery disease	0.00716	0.0171	CbGbCtD
Acenocoumarol—CYP2C19—Simvastatin—coronary artery disease	0.00683	0.0163	CbGbCtD
Acenocoumarol—CYP2C19—Lovastatin—coronary artery disease	0.00668	0.0159	CbGbCtD
Acenocoumarol—CYP3A4—Gemfibrozil—coronary artery disease	0.00636	0.0152	CbGbCtD
Acenocoumarol—CYP2C9—Rosuvastatin—coronary artery disease	0.00611	0.0146	CbGbCtD
Acenocoumarol—CYP2C19—Atorvastatin—coronary artery disease	0.00609	0.0145	CbGbCtD
Acenocoumarol—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.00595	0.0142	CbGbCtD
Acenocoumarol—CYP2C9—Simvastatin—coronary artery disease	0.00568	0.0135	CbGbCtD
Acenocoumarol—CYP2C19—Losartan—coronary artery disease	0.00557	0.0133	CbGbCtD
Acenocoumarol—CYP2C9—Lovastatin—coronary artery disease	0.00556	0.0133	CbGbCtD
Acenocoumarol—CYP2C9—Pravastatin—coronary artery disease	0.00556	0.0133	CbGbCtD
Acenocoumarol—CYP3A4—Clopidogrel—coronary artery disease	0.00551	0.0131	CbGbCtD
Acenocoumarol—CYP1A2—Losartan—coronary artery disease	0.00514	0.0123	CbGbCtD
Acenocoumarol—CYP3A4—Eplerenone—coronary artery disease	0.00512	0.0122	CbGbCtD
Acenocoumarol—CYP2C9—Atorvastatin—coronary artery disease	0.00506	0.0121	CbGbCtD
Acenocoumarol—CYP2C9—Losartan—coronary artery disease	0.00463	0.011	CbGbCtD
Acenocoumarol—CYP3A4—Enalapril—coronary artery disease	0.00457	0.0109	CbGbCtD
Acenocoumarol—CYP3A4—Rosuvastatin—coronary artery disease	0.00355	0.00847	CbGbCtD
Acenocoumarol—CYP3A4—Ezetimibe—coronary artery disease	0.00355	0.00847	CbGbCtD
Acenocoumarol—CYP3A4—Simvastatin—coronary artery disease	0.0033	0.00788	CbGbCtD
Acenocoumarol—CYP3A4—Lovastatin—coronary artery disease	0.00323	0.00771	CbGbCtD
Acenocoumarol—CYP3A4—Pravastatin—coronary artery disease	0.00323	0.00771	CbGbCtD
Acenocoumarol—CYP2C9—cardial valve—coronary artery disease	0.00303	0.433	CbGeAlD
Acenocoumarol—CYP3A4—Atorvastatin—coronary artery disease	0.00294	0.00702	CbGbCtD
Acenocoumarol—CYP3A4—Losartan—coronary artery disease	0.00269	0.00642	CbGbCtD
Acenocoumarol—Dicoumarol—VKORC1—coronary artery disease	0.0018	0.51	CrCbGaD
Acenocoumarol—VKORC1—artery—coronary artery disease	0.00154	0.219	CbGeAlD
Acenocoumarol—Phenprocoumon—VKORC1—coronary artery disease	0.00077	0.218	CrCbGaD
Acenocoumarol—Warfarin—VKORC1—coronary artery disease	0.000683	0.193	CrCbGaD
Acenocoumarol—VKORC1—heart—coronary artery disease	0.000566	0.0808	CbGeAlD
Acenocoumarol—Hepatocellular injury—Pravastatin—coronary artery disease	0.000564	0.0081	CcSEcCtD
Acenocoumarol—Ulcer—Captopril—coronary artery disease	0.000553	0.00794	CcSEcCtD
Acenocoumarol—Skin exfoliation—Niacin—coronary artery disease	0.000547	0.00785	CcSEcCtD
Acenocoumarol—Hepatocellular injury—Telmisartan—coronary artery disease	0.000538	0.00773	CcSEcCtD
Acenocoumarol—VKORC1—cardiovascular system—coronary artery disease	0.000534	0.0762	CbGeAlD
Acenocoumarol—Melaena—Enalapril—coronary artery disease	0.000533	0.00765	CcSEcCtD
Acenocoumarol—Melaena—Telmisartan—coronary artery disease	0.000525	0.00755	CcSEcCtD
Acenocoumarol—Hepatocellular injury—Captopril—coronary artery disease	0.000523	0.00751	CcSEcCtD
Acenocoumarol—Liver injury—Ramipril—coronary artery disease	0.000485	0.00697	CcSEcCtD
Acenocoumarol—Haematuria—Ticagrelor—coronary artery disease	0.000466	0.0067	CcSEcCtD
Acenocoumarol—Alopecia—Penbutolol—coronary artery disease	0.000465	0.00669	CcSEcCtD
Acenocoumarol—Skin exfoliation—Losartan—coronary artery disease	0.000455	0.00653	CcSEcCtD
Acenocoumarol—Haemoglobin—Ticagrelor—coronary artery disease	0.000441	0.00634	CcSEcCtD
Acenocoumarol—Haemorrhage—Ticagrelor—coronary artery disease	0.000439	0.00631	CcSEcCtD
Acenocoumarol—Haematuria—Rosuvastatin—coronary artery disease	0.00042	0.00603	CcSEcCtD
Acenocoumarol—Urticaria—Tirofiban—coronary artery disease	0.000419	0.00602	CcSEcCtD
Acenocoumarol—Body temperature increased—Tirofiban—coronary artery disease	0.000417	0.00599	CcSEcCtD
Acenocoumarol—Hepatocellular injury—Ramipril—coronary artery disease	0.000408	0.00587	CcSEcCtD
Acenocoumarol—Alopecia—Gemfibrozil—coronary artery disease	0.000397	0.0057	CcSEcCtD
Acenocoumarol—Hypersensitivity—Tirofiban—coronary artery disease	0.000389	0.00559	CcSEcCtD
Acenocoumarol—Haemoglobin—Acetylsalicylic acid—coronary artery disease	0.000386	0.00554	CcSEcCtD
Acenocoumarol—Haemorrhage—Acetylsalicylic acid—coronary artery disease	0.000384	0.00551	CcSEcCtD
Acenocoumarol—Haematuria—Clopidogrel—coronary artery disease	0.000358	0.00514	CcSEcCtD
Acenocoumarol—Urticaria—Pitavastatin—coronary artery disease	0.000358	0.00514	CcSEcCtD
Acenocoumarol—Haematuria—Eplerenone—coronary artery disease	0.000341	0.0049	CcSEcCtD
Acenocoumarol—Haemoglobin—Clopidogrel—coronary artery disease	0.000339	0.00487	CcSEcCtD
Acenocoumarol—Haemorrhage—Clopidogrel—coronary artery disease	0.000337	0.00484	CcSEcCtD
Acenocoumarol—Hypersensitivity—Pitavastatin—coronary artery disease	0.000332	0.00477	CcSEcCtD
Acenocoumarol—Nausea—Tirofiban—coronary artery disease	0.000314	0.0045	CcSEcCtD
Acenocoumarol—Haematuria—Olmesartan—coronary artery disease	0.000313	0.00449	CcSEcCtD
Acenocoumarol—Diarrhoea—Pitavastatin—coronary artery disease	0.000308	0.00443	CcSEcCtD
Acenocoumarol—Alopecia—Fenofibrate—coronary artery disease	0.000303	0.00435	CcSEcCtD
Acenocoumarol—Haemoglobin—Valsartan—coronary artery disease	0.000297	0.00427	CcSEcCtD
Acenocoumarol—Alopecia—Lovastatin—coronary artery disease	0.000296	0.00425	CcSEcCtD
Acenocoumarol—Body temperature increased—Penbutolol—coronary artery disease	0.000296	0.00425	CcSEcCtD
Acenocoumarol—Haemorrhage—Valsartan—coronary artery disease	0.000296	0.00425	CcSEcCtD
Acenocoumarol—Alopecia—Ezetimibe—coronary artery disease	0.00029	0.00417	CcSEcCtD
Acenocoumarol—Haemoglobin—Niacin—coronary artery disease	0.000289	0.00415	CcSEcCtD
Acenocoumarol—Haemorrhage—Niacin—coronary artery disease	0.000288	0.00413	CcSEcCtD
Acenocoumarol—Haematuria—Telmisartan—coronary artery disease	0.000287	0.00412	CcSEcCtD
Acenocoumarol—Dermatitis—Pitavastatin—coronary artery disease	0.000284	0.00408	CcSEcCtD
Acenocoumarol—Alopecia—Simvastatin—coronary artery disease	0.000277	0.00398	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Gemfibrozil—coronary artery disease	0.000276	0.00396	CcSEcCtD
Acenocoumarol—Haematuria—Perindopril—coronary artery disease	0.000271	0.00389	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Ticagrelor—coronary artery disease	0.000269	0.00387	CcSEcCtD
Acenocoumarol—ALB—heart—coronary artery disease	0.000268	0.0383	CbGeAlD
Acenocoumarol—Nausea—Pitavastatin—coronary artery disease	0.000268	0.00385	CcSEcCtD
Acenocoumarol—Alopecia—Valsartan—coronary artery disease	0.000261	0.00375	CcSEcCtD
Acenocoumarol—Alopecia—Olmesartan—coronary artery disease	0.00026	0.00374	CcSEcCtD
Acenocoumarol—Haemoglobin—Perindopril—coronary artery disease	0.000256	0.00368	CcSEcCtD
Acenocoumarol—Diarrhoea—Penbutolol—coronary artery disease	0.000256	0.00368	CcSEcCtD
Acenocoumarol—Haemorrhage—Perindopril—coronary artery disease	0.000255	0.00366	CcSEcCtD
Acenocoumarol—Alopecia—Niacin—coronary artery disease	0.000254	0.00365	CcSEcCtD
Acenocoumarol—Urticaria—Gemfibrozil—coronary artery disease	0.000254	0.00364	CcSEcCtD
Acenocoumarol—Alopecia—Pravastatin—coronary artery disease	0.00025	0.00359	CcSEcCtD
Acenocoumarol—Body temperature increased—Ticagrelor—coronary artery disease	0.000247	0.00354	CcSEcCtD
Acenocoumarol—Alopecia—Trandolapril—coronary artery disease	0.000243	0.00349	CcSEcCtD
Acenocoumarol—Alopecia—Enalapril—coronary artery disease	0.000242	0.00348	CcSEcCtD
Acenocoumarol—Alopecia—Captopril—coronary artery disease	0.000232	0.00333	CcSEcCtD
Acenocoumarol—Hypersensitivity—Ticagrelor—coronary artery disease	0.00023	0.0033	CcSEcCtD
Acenocoumarol—ORM1—blood—coronary artery disease	0.000228	0.0326	CbGeAlD
Acenocoumarol—Alopecia—Perindopril—coronary artery disease	0.000225	0.00324	CcSEcCtD
Acenocoumarol—Urticaria—Rosuvastatin—coronary artery disease	0.000223	0.0032	CcSEcCtD
Acenocoumarol—Nausea—Penbutolol—coronary artery disease	0.000222	0.00319	CcSEcCtD
Acenocoumarol—Diarrhoea—Gemfibrozil—coronary artery disease	0.000218	0.00314	CcSEcCtD
Acenocoumarol—Urticaria—Acetylsalicylic acid—coronary artery disease	0.000217	0.00311	CcSEcCtD
Acenocoumarol—Diarrhoea—Ticagrelor—coronary artery disease	0.000213	0.00307	CcSEcCtD
Acenocoumarol—Decreased appetite—Fenofibrate—coronary artery disease	0.000212	0.00304	CcSEcCtD
Acenocoumarol—Alopecia—Losartan—coronary artery disease	0.000211	0.00304	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Fenofibrate—coronary artery disease	0.00021	0.00302	CcSEcCtD
Acenocoumarol—Hypersensitivity—Rosuvastatin—coronary artery disease	0.000207	0.00297	CcSEcCtD
Acenocoumarol—Decreased appetite—Lovastatin—coronary artery disease	0.000207	0.00297	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Clopidogrel—coronary artery disease	0.000207	0.00297	CcSEcCtD
Acenocoumarol—Vomiting—Gemfibrozil—coronary artery disease	0.000203	0.00292	CcSEcCtD
Acenocoumarol—Decreased appetite—Ezetimibe—coronary artery disease	0.000203	0.00291	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Ezetimibe—coronary artery disease	0.000201	0.00289	CcSEcCtD
Acenocoumarol—Dermatitis—Gemfibrozil—coronary artery disease	0.000201	0.00289	CcSEcCtD
Acenocoumarol—Hypersensitivity—Acetylsalicylic acid—coronary artery disease	0.000201	0.00289	CcSEcCtD
Acenocoumarol—Vomiting—Ticagrelor—coronary artery disease	0.000198	0.00285	CcSEcCtD
Acenocoumarol—Haematuria—Lisinopril—coronary artery disease	0.000198	0.00284	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Eplerenone—coronary artery disease	0.000197	0.00283	CcSEcCtD
Acenocoumarol—Dermatitis—Ticagrelor—coronary artery disease	0.000196	0.00282	CcSEcCtD
Acenocoumarol—Urticaria—Fenofibrate—coronary artery disease	0.000194	0.00278	CcSEcCtD
Acenocoumarol—Decreased appetite—Simvastatin—coronary artery disease	0.000193	0.00278	CcSEcCtD
Acenocoumarol—Body temperature increased—Fenofibrate—coronary artery disease	0.000193	0.00277	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Simvastatin—coronary artery disease	0.000192	0.00276	CcSEcCtD
Acenocoumarol—Diarrhoea—Rosuvastatin—coronary artery disease	0.000192	0.00276	CcSEcCtD
Acenocoumarol—Urticaria—Clopidogrel—coronary artery disease	0.00019	0.00273	CcSEcCtD
Acenocoumarol—Nausea—Gemfibrozil—coronary artery disease	0.00019	0.00272	CcSEcCtD
Acenocoumarol—Body temperature increased—Clopidogrel—coronary artery disease	0.000189	0.00272	CcSEcCtD
Acenocoumarol—Urticaria—Lovastatin—coronary artery disease	0.000189	0.00271	CcSEcCtD
Acenocoumarol—Body temperature increased—Lovastatin—coronary artery disease	0.000188	0.0027	CcSEcCtD
Acenocoumarol—Diarrhoea—Acetylsalicylic acid—coronary artery disease	0.000187	0.00268	CcSEcCtD
Acenocoumarol—Urticaria—Ezetimibe—coronary artery disease	0.000185	0.00266	CcSEcCtD
Acenocoumarol—Nausea—Ticagrelor—coronary artery disease	0.000185	0.00266	CcSEcCtD
Acenocoumarol—Body temperature increased—Ezetimibe—coronary artery disease	0.000184	0.00265	CcSEcCtD
Acenocoumarol—Decreased appetite—Valsartan—coronary artery disease	0.000183	0.00262	CcSEcCtD
Acenocoumarol—Decreased appetite—Olmesartan—coronary artery disease	0.000182	0.00261	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Valsartan—coronary artery disease	0.000181	0.00261	CcSEcCtD
Acenocoumarol—Alopecia—Ramipril—coronary artery disease	0.000181	0.0026	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Olmesartan—coronary artery disease	0.000181	0.00259	CcSEcCtD
Acenocoumarol—Body temperature increased—Eplerenone—coronary artery disease	0.000181	0.00259	CcSEcCtD
Acenocoumarol—Hypersensitivity—Fenofibrate—coronary artery disease	0.00018	0.00258	CcSEcCtD
Acenocoumarol—Decreased appetite—Niacin—coronary artery disease	0.000178	0.00255	CcSEcCtD
Acenocoumarol—Alopecia—Timolol—coronary artery disease	0.000177	0.00255	CcSEcCtD
Acenocoumarol—Dermatitis—Rosuvastatin—coronary artery disease	0.000177	0.00254	CcSEcCtD
Acenocoumarol—Urticaria—Simvastatin—coronary artery disease	0.000177	0.00254	CcSEcCtD
Acenocoumarol—Hypersensitivity—Clopidogrel—coronary artery disease	0.000176	0.00253	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Niacin—coronary artery disease	0.000176	0.00253	CcSEcCtD
Acenocoumarol—Body temperature increased—Simvastatin—coronary artery disease	0.000176	0.00253	CcSEcCtD
Acenocoumarol—Hypersensitivity—Lovastatin—coronary artery disease	0.000175	0.00252	CcSEcCtD
Acenocoumarol—Decreased appetite—Pravastatin—coronary artery disease	0.000175	0.00251	CcSEcCtD
Acenocoumarol—Vomiting—Acetylsalicylic acid—coronary artery disease	0.000173	0.00249	CcSEcCtD
Acenocoumarol—Hypersensitivity—Ezetimibe—coronary artery disease	0.000172	0.00247	CcSEcCtD
Acenocoumarol—Dermatitis—Acetylsalicylic acid—coronary artery disease	0.000172	0.00247	CcSEcCtD
Acenocoumarol—Decreased appetite—Trandolapril—coronary artery disease	0.00017	0.00244	CcSEcCtD
Acenocoumarol—Decreased appetite—Enalapril—coronary artery disease	0.000169	0.00243	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Trandolapril—coronary artery disease	0.000169	0.00242	CcSEcCtD
Acenocoumarol—CYP2C9—heart—coronary artery disease	0.000168	0.0239	CbGeAlD
Acenocoumarol—Urticaria—Valsartan—coronary artery disease	0.000167	0.0024	CcSEcCtD
Acenocoumarol—Decreased appetite—Telmisartan—coronary artery disease	0.000167	0.0024	CcSEcCtD
Acenocoumarol—Nausea—Rosuvastatin—coronary artery disease	0.000167	0.0024	CcSEcCtD
Acenocoumarol—Diarrhoea—Fenofibrate—coronary artery disease	0.000167	0.00239	CcSEcCtD
Acenocoumarol—Urticaria—Olmesartan—coronary artery disease	0.000166	0.00239	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Telmisartan—coronary artery disease	0.000166	0.00238	CcSEcCtD
Acenocoumarol—Body temperature increased—Olmesartan—coronary artery disease	0.000165	0.00237	CcSEcCtD
Acenocoumarol—Alopecia—Lisinopril—coronary artery disease	0.000164	0.00236	CcSEcCtD
Acenocoumarol—Hypersensitivity—Simvastatin—coronary artery disease	0.000164	0.00236	CcSEcCtD
Acenocoumarol—Diarrhoea—Clopidogrel—coronary artery disease	0.000164	0.00235	CcSEcCtD
Acenocoumarol—Diarrhoea—Lovastatin—coronary artery disease	0.000163	0.00234	CcSEcCtD
Acenocoumarol—Urticaria—Niacin—coronary artery disease	0.000162	0.00233	CcSEcCtD
Acenocoumarol—Decreased appetite—Captopril—coronary artery disease	0.000162	0.00233	CcSEcCtD
Acenocoumarol—Nausea—Acetylsalicylic acid—coronary artery disease	0.000162	0.00233	CcSEcCtD
Acenocoumarol—Body temperature increased—Niacin—coronary artery disease	0.000162	0.00232	CcSEcCtD
Acenocoumarol—CYP2C19—blood—coronary artery disease	0.000161	0.023	CbGeAlD
Acenocoumarol—Urticaria—Pravastatin—coronary artery disease	0.00016	0.0023	CcSEcCtD
Acenocoumarol—Diarrhoea—Ezetimibe—coronary artery disease	0.00016	0.00229	CcSEcCtD
Acenocoumarol—Body temperature increased—Pravastatin—coronary artery disease	0.000159	0.00228	CcSEcCtD
Acenocoumarol—CYP2C9—cardiovascular system—coronary artery disease	0.000158	0.0226	CbGeAlD
Acenocoumarol—Decreased appetite—Perindopril—coronary artery disease	0.000158	0.00226	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Perindopril—coronary artery disease	0.000156	0.00225	CcSEcCtD
Acenocoumarol—Diarrhoea—Eplerenone—coronary artery disease	0.000156	0.00224	CcSEcCtD
Acenocoumarol—Urticaria—Trandolapril—coronary artery disease	0.000155	0.00223	CcSEcCtD
Acenocoumarol—Vomiting—Fenofibrate—coronary artery disease	0.000155	0.00223	CcSEcCtD
Acenocoumarol—Hypersensitivity—Valsartan—coronary artery disease	0.000155	0.00222	CcSEcCtD
Acenocoumarol—Urticaria—Enalapril—coronary artery disease	0.000155	0.00222	CcSEcCtD
Acenocoumarol—Body temperature increased—Trandolapril—coronary artery disease	0.000154	0.00222	CcSEcCtD
Acenocoumarol—Body temperature increased—Enalapril—coronary artery disease	0.000154	0.00221	CcSEcCtD
Acenocoumarol—Dermatitis—Fenofibrate—coronary artery disease	0.000153	0.0022	CcSEcCtD
Acenocoumarol—Decreased appetite—Furosemide—coronary artery disease	0.000153	0.0022	CcSEcCtD
Acenocoumarol—Urticaria—Telmisartan—coronary artery disease	0.000152	0.00219	CcSEcCtD
Acenocoumarol—Vomiting—Clopidogrel—coronary artery disease	0.000152	0.00219	CcSEcCtD
Acenocoumarol—Diarrhoea—Simvastatin—coronary artery disease	0.000152	0.00219	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Furosemide—coronary artery disease	0.000152	0.00218	CcSEcCtD
Acenocoumarol—Body temperature increased—Telmisartan—coronary artery disease	0.000152	0.00218	CcSEcCtD
Acenocoumarol—Vomiting—Lovastatin—coronary artery disease	0.000151	0.00217	CcSEcCtD
Acenocoumarol—Dermatitis—Clopidogrel—coronary artery disease	0.000151	0.00217	CcSEcCtD
Acenocoumarol—Hypersensitivity—Niacin—coronary artery disease	0.000151	0.00216	CcSEcCtD
Acenocoumarol—Dermatitis—Lovastatin—coronary artery disease	0.00015	0.00215	CcSEcCtD
Acenocoumarol—Vomiting—Ezetimibe—coronary artery disease	0.000148	0.00213	CcSEcCtD
Acenocoumarol—Hypersensitivity—Pravastatin—coronary artery disease	0.000148	0.00213	CcSEcCtD
Acenocoumarol—Decreased appetite—Losartan—coronary artery disease	0.000148	0.00212	CcSEcCtD
Acenocoumarol—Body temperature increased—Captopril—coronary artery disease	0.000148	0.00212	CcSEcCtD
Acenocoumarol—Dermatitis—Ezetimibe—coronary artery disease	0.000147	0.00211	CcSEcCtD
Acenocoumarol—Vomiting—Eplerenone—coronary artery disease	0.000145	0.00209	CcSEcCtD
Acenocoumarol—Nausea—Fenofibrate—coronary artery disease	0.000145	0.00208	CcSEcCtD
Acenocoumarol—Urticaria—Perindopril—coronary artery disease	0.000144	0.00207	CcSEcCtD
Acenocoumarol—Hypersensitivity—Trandolapril—coronary artery disease	0.000144	0.00207	CcSEcCtD
Acenocoumarol—Dermatitis—Eplerenone—coronary artery disease	0.000144	0.00207	CcSEcCtD
Acenocoumarol—Diarrhoea—Valsartan—coronary artery disease	0.000144	0.00207	CcSEcCtD
Acenocoumarol—Hypersensitivity—Enalapril—coronary artery disease	0.000143	0.00206	CcSEcCtD
Acenocoumarol—Body temperature increased—Perindopril—coronary artery disease	0.000143	0.00206	CcSEcCtD
Acenocoumarol—Diarrhoea—Olmesartan—coronary artery disease	0.000143	0.00206	CcSEcCtD
Acenocoumarol—Nausea—Clopidogrel—coronary artery disease	0.000142	0.00204	CcSEcCtD
Acenocoumarol—Vomiting—Simvastatin—coronary artery disease	0.000141	0.00203	CcSEcCtD
Acenocoumarol—Hypersensitivity—Telmisartan—coronary artery disease	0.000141	0.00203	CcSEcCtD
Acenocoumarol—Nausea—Lovastatin—coronary artery disease	0.000141	0.00203	CcSEcCtD
Acenocoumarol—Dermatitis—Simvastatin—coronary artery disease	0.00014	0.00201	CcSEcCtD
Acenocoumarol—Urticaria—Furosemide—coronary artery disease	0.00014	0.00201	CcSEcCtD
Acenocoumarol—Diarrhoea—Niacin—coronary artery disease	0.00014	0.00201	CcSEcCtD
Acenocoumarol—Body temperature increased—Furosemide—coronary artery disease	0.000139	0.002	CcSEcCtD
Acenocoumarol—Nausea—Ezetimibe—coronary artery disease	0.000139	0.00199	CcSEcCtD
Acenocoumarol—Diarrhoea—Pravastatin—coronary artery disease	0.000138	0.00198	CcSEcCtD
Acenocoumarol—Nausea—Eplerenone—coronary artery disease	0.000136	0.00195	CcSEcCtD
Acenocoumarol—Urticaria—Losartan—coronary artery disease	0.000135	0.00194	CcSEcCtD
Acenocoumarol—Body temperature increased—Losartan—coronary artery disease	0.000134	0.00193	CcSEcCtD
Acenocoumarol—Diarrhoea—Trandolapril—coronary artery disease	0.000134	0.00192	CcSEcCtD
Acenocoumarol—Vomiting—Valsartan—coronary artery disease	0.000134	0.00192	CcSEcCtD
Acenocoumarol—Diarrhoea—Enalapril—coronary artery disease	0.000133	0.00191	CcSEcCtD
Acenocoumarol—Vomiting—Olmesartan—coronary artery disease	0.000133	0.00191	CcSEcCtD
Acenocoumarol—Dermatitis—Valsartan—coronary artery disease	0.000132	0.0019	CcSEcCtD
Acenocoumarol—Nausea—Simvastatin—coronary artery disease	0.000132	0.0019	CcSEcCtD
Acenocoumarol—CYP1A2—blood—coronary artery disease	0.000132	0.0188	CbGeAlD
Acenocoumarol—Dermatitis—Olmesartan—coronary artery disease	0.000132	0.00189	CcSEcCtD
Acenocoumarol—Diarrhoea—Telmisartan—coronary artery disease	0.000131	0.00189	CcSEcCtD
Acenocoumarol—Vomiting—Niacin—coronary artery disease	0.00013	0.00187	CcSEcCtD
Acenocoumarol—Hypersensitivity—Furosemide—coronary artery disease	0.00013	0.00186	CcSEcCtD
Acenocoumarol—Dermatitis—Niacin—coronary artery disease	0.000129	0.00185	CcSEcCtD
Acenocoumarol—Vomiting—Pravastatin—coronary artery disease	0.000128	0.00184	CcSEcCtD
Acenocoumarol—Diarrhoea—Captopril—coronary artery disease	0.000128	0.00183	CcSEcCtD
Acenocoumarol—Dermatitis—Pravastatin—coronary artery disease	0.000127	0.00182	CcSEcCtD
Acenocoumarol—Decreased appetite—Ramipril—coronary artery disease	0.000127	0.00182	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Ramipril—coronary artery disease	0.000126	0.00181	CcSEcCtD
Acenocoumarol—Hypersensitivity—Losartan—coronary artery disease	0.000125	0.0018	CcSEcCtD
Acenocoumarol—CYP2C9—blood—coronary artery disease	0.000125	0.0178	CbGeAlD
Acenocoumarol—Nausea—Valsartan—coronary artery disease	0.000125	0.00179	CcSEcCtD
Acenocoumarol—Nausea—Olmesartan—coronary artery disease	0.000124	0.00178	CcSEcCtD
Acenocoumarol—Vomiting—Trandolapril—coronary artery disease	0.000124	0.00178	CcSEcCtD
Acenocoumarol—Diarrhoea—Perindopril—coronary artery disease	0.000124	0.00178	CcSEcCtD
Acenocoumarol—Decreased appetite—Timolol—coronary artery disease	0.000124	0.00178	CcSEcCtD
Acenocoumarol—Vomiting—Enalapril—coronary artery disease	0.000124	0.00178	CcSEcCtD
Acenocoumarol—Dermatitis—Trandolapril—coronary artery disease	0.000123	0.00177	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Timolol—coronary artery disease	0.000123	0.00177	CcSEcCtD
Acenocoumarol—Dermatitis—Enalapril—coronary artery disease	0.000123	0.00176	CcSEcCtD
Acenocoumarol—Vomiting—Telmisartan—coronary artery disease	0.000122	0.00175	CcSEcCtD
Acenocoumarol—Nausea—Niacin—coronary artery disease	0.000121	0.00174	CcSEcCtD
Acenocoumarol—Dermatitis—Telmisartan—coronary artery disease	0.000121	0.00174	CcSEcCtD
Acenocoumarol—Diarrhoea—Furosemide—coronary artery disease	0.000121	0.00173	CcSEcCtD
Acenocoumarol—Nausea—Pravastatin—coronary artery disease	0.000119	0.00172	CcSEcCtD
Acenocoumarol—Vomiting—Captopril—coronary artery disease	0.000119	0.0017	CcSEcCtD
Acenocoumarol—Dermatitis—Captopril—coronary artery disease	0.000118	0.00169	CcSEcCtD
Acenocoumarol—Diarrhoea—Losartan—coronary artery disease	0.000116	0.00167	CcSEcCtD
Acenocoumarol—Nausea—Trandolapril—coronary artery disease	0.000116	0.00167	CcSEcCtD
Acenocoumarol—Urticaria—Ramipril—coronary artery disease	0.000116	0.00166	CcSEcCtD
Acenocoumarol—Nausea—Enalapril—coronary artery disease	0.000116	0.00166	CcSEcCtD
Acenocoumarol—Vomiting—Perindopril—coronary artery disease	0.000115	0.00165	CcSEcCtD
Acenocoumarol—Body temperature increased—Ramipril—coronary artery disease	0.000115	0.00165	CcSEcCtD
Acenocoumarol—Decreased appetite—Lisinopril—coronary artery disease	0.000115	0.00165	CcSEcCtD
Acenocoumarol—Dermatitis—Perindopril—coronary artery disease	0.000114	0.00164	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Lisinopril—coronary artery disease	0.000114	0.00164	CcSEcCtD
Acenocoumarol—Nausea—Telmisartan—coronary artery disease	0.000114	0.00164	CcSEcCtD
Acenocoumarol—Urticaria—Timolol—coronary artery disease	0.000113	0.00163	CcSEcCtD
Acenocoumarol—Body temperature increased—Timolol—coronary artery disease	0.000113	0.00162	CcSEcCtD
Acenocoumarol—Vomiting—Furosemide—coronary artery disease	0.000112	0.00161	CcSEcCtD
Acenocoumarol—Dermatitis—Furosemide—coronary artery disease	0.000111	0.00159	CcSEcCtD
Acenocoumarol—Nausea—Captopril—coronary artery disease	0.000111	0.00159	CcSEcCtD
Acenocoumarol—Vomiting—Losartan—coronary artery disease	0.000108	0.00155	CcSEcCtD
Acenocoumarol—Nausea—Perindopril—coronary artery disease	0.000108	0.00155	CcSEcCtD
Acenocoumarol—Hypersensitivity—Ramipril—coronary artery disease	0.000107	0.00154	CcSEcCtD
Acenocoumarol—Dermatitis—Losartan—coronary artery disease	0.000107	0.00154	CcSEcCtD
Acenocoumarol—Urticaria—Lisinopril—coronary artery disease	0.000105	0.00151	CcSEcCtD
Acenocoumarol—Hypersensitivity—Timolol—coronary artery disease	0.000105	0.00151	CcSEcCtD
Acenocoumarol—Nausea—Furosemide—coronary artery disease	0.000105	0.0015	CcSEcCtD
Acenocoumarol—Body temperature increased—Lisinopril—coronary artery disease	0.000104	0.0015	CcSEcCtD
Acenocoumarol—Nausea—Losartan—coronary artery disease	0.000101	0.00145	CcSEcCtD
Acenocoumarol—Diarrhoea—Ramipril—coronary artery disease	9.97e-05	0.00143	CcSEcCtD
Acenocoumarol—Diarrhoea—Timolol—coronary artery disease	9.75e-05	0.0014	CcSEcCtD
Acenocoumarol—Hypersensitivity—Lisinopril—coronary artery disease	9.74e-05	0.0014	CcSEcCtD
Acenocoumarol—CYP3A4—blood—coronary artery disease	9.54e-05	0.0136	CbGeAlD
Acenocoumarol—Warfarin—CYP2C19—coronary artery disease	9.5e-05	0.0269	CrCbGaD
Acenocoumarol—Vomiting—Ramipril—coronary artery disease	9.27e-05	0.00133	CcSEcCtD
Acenocoumarol—Dermatitis—Ramipril—coronary artery disease	9.18e-05	0.00132	CcSEcCtD
Acenocoumarol—Vomiting—Timolol—coronary artery disease	9.06e-05	0.0013	CcSEcCtD
Acenocoumarol—Diarrhoea—Lisinopril—coronary artery disease	9.04e-05	0.0013	CcSEcCtD
Acenocoumarol—Dermatitis—Timolol—coronary artery disease	8.97e-05	0.00129	CcSEcCtD
Acenocoumarol—Nausea—Ramipril—coronary artery disease	8.66e-05	0.00124	CcSEcCtD
Acenocoumarol—Nausea—Timolol—coronary artery disease	8.46e-05	0.00122	CcSEcCtD
Acenocoumarol—Vomiting—Lisinopril—coronary artery disease	8.4e-05	0.00121	CcSEcCtD
Acenocoumarol—Dermatitis—Lisinopril—coronary artery disease	8.33e-05	0.0012	CcSEcCtD
Acenocoumarol—Nausea—Lisinopril—coronary artery disease	7.85e-05	0.00113	CcSEcCtD
Acenocoumarol—Flunitrazepam—CYP2C19—coronary artery disease	6.93e-05	0.0196	CrCbGaD
Acenocoumarol—Phenprocoumon—ALB—coronary artery disease	5.94e-05	0.0168	CrCbGaD
Acenocoumarol—Warfarin—ALB—coronary artery disease	5.27e-05	0.0149	CrCbGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	4.39e-06	0.000102	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—LPA—coronary artery disease	4.37e-06	0.000101	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—CTGF—coronary artery disease	4.37e-06	0.000101	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—SLC9A1—coronary artery disease	4.34e-06	0.000101	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—GSTT1—coronary artery disease	4.34e-06	0.000101	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—GOT2—coronary artery disease	4.33e-06	0.0001	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—HMGCR—coronary artery disease	4.33e-06	0.0001	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—CETP—coronary artery disease	4.29e-06	9.96e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—GCLC—coronary artery disease	4.29e-06	9.96e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—DCN—coronary artery disease	4.28e-06	9.93e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—SLC27A1—coronary artery disease	4.26e-06	9.89e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—SDC1—coronary artery disease	4.25e-06	9.85e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—PLCB3—coronary artery disease	4.23e-06	9.81e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—APOA5—coronary artery disease	4.19e-06	9.71e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—CPT1B—coronary artery disease	4.18e-06	9.7e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—LCAT—coronary artery disease	4.18e-06	9.7e-05	CbGpPWpGaD
Acenocoumarol—ALB—Platelet activation, signaling and aggregation—AKT1—coronary artery disease	4.18e-06	9.7e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—ALDH2—coronary artery disease	4.16e-06	9.66e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—P4HB—coronary artery disease	4.1e-06	9.52e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—APOA4—coronary artery disease	4.1e-06	9.52e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	4.07e-06	9.43e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	4.06e-06	9.42e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—LIPC—coronary artery disease	4.06e-06	9.42e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—HBA1—coronary artery disease	4.06e-06	9.42e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—CYP2C19—coronary artery disease	4.06e-06	9.42e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—PIK3C2A—coronary artery disease	4.06e-06	9.42e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—APOC3—coronary artery disease	4.03e-06	9.36e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—PLA2G1B—coronary artery disease	4.03e-06	9.35e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—PSMB5—coronary artery disease	4.01e-06	9.31e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—PSMA6—coronary artery disease	4.01e-06	9.31e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—LDLR—coronary artery disease	4.01e-06	9.3e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	4e-06	9.29e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	4e-06	9.29e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	3.98e-06	9.24e-05	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—PLCB1—coronary artery disease	3.98e-06	9.23e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—PDHA1—coronary artery disease	3.96e-06	9.19e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—GCLM—coronary artery disease	3.96e-06	9.19e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—SLC9A1—coronary artery disease	3.96e-06	9.19e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—GSTT1—coronary artery disease	3.96e-06	9.19e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	3.94e-06	9.14e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—CTGF—coronary artery disease	3.92e-06	9.09e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—GCLC—coronary artery disease	3.92e-06	9.09e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—CETP—coronary artery disease	3.92e-06	9.09e-05	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	3.9e-06	9.06e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—HMGCR—coronary artery disease	3.88e-06	9.01e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—GOT2—coronary artery disease	3.88e-06	9.01e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—SDC1—coronary artery disease	3.87e-06	8.98e-05	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—ABCA1—coronary artery disease	3.86e-06	8.95e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—TXNRD1—coronary artery disease	3.84e-06	8.91e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—CYP11B2—coronary artery disease	3.84e-06	8.91e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—VCAN—coronary artery disease	3.8e-06	8.81e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—SLC22A3—coronary artery disease	3.78e-06	8.77e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—ALDOA—coronary artery disease	3.77e-06	8.74e-05	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—GOT1—coronary artery disease	3.73e-06	8.67e-05	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—GGT1—coronary artery disease	3.73e-06	8.67e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—ARNTL—coronary artery disease	3.73e-06	8.65e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—HADH—coronary artery disease	3.73e-06	8.65e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—DCN—coronary artery disease	3.66e-06	8.49e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—PSMA6—coronary artery disease	3.66e-06	8.49e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—PSMB5—coronary artery disease	3.66e-06	8.49e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	3.65e-06	8.47e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—CTGF—coronary artery disease	3.57e-06	8.29e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—PLCB1—coronary artery disease	3.57e-06	8.29e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—ALDH2—coronary artery disease	3.56e-06	8.26e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—HMGCR—coronary artery disease	3.54e-06	8.22e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—GOT2—coronary artery disease	3.54e-06	8.22e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—APOA2—coronary artery disease	3.53e-06	8.2e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	3.53e-06	8.2e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—GPX2—coronary artery disease	3.53e-06	8.2e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	3.5e-06	8.13e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—SULT1A1—coronary artery disease	3.49e-06	8.1e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—GPX4—coronary artery disease	3.49e-06	8.1e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—ABCG5—coronary artery disease	3.49e-06	8.1e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—HK1—coronary artery disease	3.49e-06	8.1e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	3.47e-06	8.05e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—LIPC—coronary artery disease	3.47e-06	8.05e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—CYP2C19—coronary artery disease	3.47e-06	8.05e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—HBA1—coronary artery disease	3.47e-06	8.05e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—PIK3C2A—coronary artery disease	3.47e-06	8.05e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—ABCA1—coronary artery disease	3.46e-06	8.03e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—HADHA—coronary artery disease	3.45e-06	8e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—APOC3—coronary artery disease	3.45e-06	8e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—LDLR—coronary artery disease	3.43e-06	7.95e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	3.42e-06	7.94e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—GSTA1—coronary artery disease	3.41e-06	7.91e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—GSTT1—coronary artery disease	3.38e-06	7.86e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—SLC9A1—coronary artery disease	3.38e-06	7.86e-05	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—VEGFA—coronary artery disease	3.38e-06	7.83e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—LPA—coronary artery disease	3.37e-06	7.82e-05	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—GSTP1—coronary artery disease	3.35e-06	7.78e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—GGT1—coronary artery disease	3.35e-06	7.78e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—GOT1—coronary artery disease	3.35e-06	7.78e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—GCLC—coronary artery disease	3.35e-06	7.76e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—CETP—coronary artery disease	3.35e-06	7.76e-05	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—PPARGC1A—coronary artery disease	3.32e-06	7.71e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—SDC1—coronary artery disease	3.31e-06	7.68e-05	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—HMOX1—coronary artery disease	3.31e-06	7.68e-05	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—CAT—coronary artery disease	3.26e-06	7.57e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—PLCB3—coronary artery disease	3.26e-06	7.57e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—PLCB1—coronary artery disease	3.26e-06	7.56e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—APOA5—coronary artery disease	3.23e-06	7.5e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	3.19e-06	7.41e-05	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—APOB—coronary artery disease	3.17e-06	7.35e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—P4HB—coronary artery disease	3.17e-06	7.35e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—ABCA1—coronary artery disease	3.16e-06	7.32e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—PSMB5—coronary artery disease	3.13e-06	7.25e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—PSMA6—coronary artery disease	3.13e-06	7.25e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	3.12e-06	7.24e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	3.11e-06	7.22e-05	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—TGFB1—coronary artery disease	3.1e-06	7.19e-05	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—GSTM1—coronary artery disease	3.08e-06	7.15e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—GGT1—coronary artery disease	3.06e-06	7.09e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—GOT1—coronary artery disease	3.06e-06	7.09e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—CTGF—coronary artery disease	3.05e-06	7.09e-05	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—MAPK1—coronary artery disease	3.04e-06	7.05e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—GOT2—coronary artery disease	3.03e-06	7.02e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—HMGCR—coronary artery disease	3.03e-06	7.02e-05	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—LPL—coronary artery disease	3.03e-06	7.02e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—GSTP1—coronary artery disease	3.01e-06	6.99e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—PPARGC1A—coronary artery disease	2.98e-06	6.92e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—HMOX1—coronary artery disease	2.97e-06	6.89e-05	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—GPX1—coronary artery disease	2.95e-06	6.85e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—VCAN—coronary artery disease	2.93e-06	6.8e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—CAT—coronary artery disease	2.93e-06	6.8e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—ALDOA—coronary artery disease	2.91e-06	6.75e-05	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—CD36—coronary artery disease	2.87e-06	6.67e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—APOB—coronary artery disease	2.84e-06	6.6e-05	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—PPP2CA—coronary artery disease	2.84e-06	6.59e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—DCN—coronary artery disease	2.82e-06	6.55e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—PLCB1—coronary artery disease	2.78e-06	6.46e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—GSTM1—coronary artery disease	2.77e-06	6.42e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—ALDH2—coronary artery disease	2.75e-06	6.37e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—GSTP1—coronary artery disease	2.75e-06	6.37e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	2.73e-06	6.33e-05	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—MTHFR—coronary artery disease	2.72e-06	6.32e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	2.72e-06	6.31e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—LPL—coronary artery disease	2.72e-06	6.3e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—HMOX1—coronary artery disease	2.71e-06	6.28e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—ABCA1—coronary artery disease	2.7e-06	6.26e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	2.68e-06	6.21e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—HBA1—coronary artery disease	2.68e-06	6.21e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—CYP2C19—coronary artery disease	2.68e-06	6.21e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—LIPC—coronary artery disease	2.68e-06	6.21e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—CAT—coronary artery disease	2.67e-06	6.2e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—APOC3—coronary artery disease	2.66e-06	6.17e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—GPX1—coronary artery disease	2.65e-06	6.15e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—LDLR—coronary artery disease	2.64e-06	6.14e-05	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—PIK3CA—coronary artery disease	2.64e-06	6.12e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—GSTT1—coronary artery disease	2.61e-06	6.06e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—SLC9A1—coronary artery disease	2.61e-06	6.06e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—GOT1—coronary artery disease	2.61e-06	6.06e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—GGT1—coronary artery disease	2.61e-06	6.06e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—APOB—coronary artery disease	2.59e-06	6.02e-05	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—AGT—coronary artery disease	2.59e-06	6.01e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—GCLC—coronary artery disease	2.58e-06	5.99e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—CETP—coronary artery disease	2.58e-06	5.99e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—CD36—coronary artery disease	2.58e-06	5.99e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—SDC1—coronary artery disease	2.55e-06	5.93e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—PPP2CA—coronary artery disease	2.55e-06	5.91e-05	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—APOE—coronary artery disease	2.54e-06	5.89e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—GSTM1—coronary artery disease	2.52e-06	5.86e-05	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—APOA1—coronary artery disease	2.51e-06	5.82e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—LPL—coronary artery disease	2.48e-06	5.75e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—MTHFR—coronary artery disease	2.45e-06	5.68e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—GPX1—coronary artery disease	2.42e-06	5.61e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—PSMA6—coronary artery disease	2.41e-06	5.6e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—PSMB5—coronary artery disease	2.41e-06	5.6e-05	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.4e-06	5.57e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—CTGF—coronary artery disease	2.36e-06	5.47e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—CD36—coronary artery disease	2.35e-06	5.46e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—GSTP1—coronary artery disease	2.35e-06	5.44e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—HMGCR—coronary artery disease	2.34e-06	5.42e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—GOT2—coronary artery disease	2.34e-06	5.42e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—PPARGC1A—coronary artery disease	2.32e-06	5.39e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—PPP2CA—coronary artery disease	2.32e-06	5.39e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—AGT—coronary artery disease	2.32e-06	5.39e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—HMOX1—coronary artery disease	2.31e-06	5.37e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—CAT—coronary artery disease	2.28e-06	5.3e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—APOE—coronary artery disease	2.28e-06	5.28e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—APOA1—coronary artery disease	2.25e-06	5.22e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—MTHFR—coronary artery disease	2.23e-06	5.17e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—APOB—coronary artery disease	2.22e-06	5.14e-05	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—PPARG—coronary artery disease	2.21e-06	5.13e-05	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—POMC—coronary artery disease	2.18e-06	5.06e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—GSTM1—coronary artery disease	2.16e-06	5e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.16e-06	5e-05	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—AKT1—coronary artery disease	2.15e-06	5e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—PLCB1—coronary artery disease	2.15e-06	4.98e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—AGT—coronary artery disease	2.12e-06	4.92e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—LPL—coronary artery disease	2.12e-06	4.91e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—ABCA1—coronary artery disease	2.08e-06	4.83e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—APOE—coronary artery disease	2.08e-06	4.82e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—GPX1—coronary artery disease	2.06e-06	4.79e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—APOA1—coronary artery disease	2.05e-06	4.76e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—GOT1—coronary artery disease	2.02e-06	4.68e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—GGT1—coronary artery disease	2.02e-06	4.68e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—CD36—coronary artery disease	2.01e-06	4.67e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—PPP2CA—coronary artery disease	1.99e-06	4.61e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—PPARG—coronary artery disease	1.98e-06	4.6e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.97e-06	4.56e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—POMC—coronary artery disease	1.96e-06	4.54e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—MTHFR—coronary artery disease	1.91e-06	4.42e-05	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—NOS3—coronary artery disease	1.9e-06	4.41e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—GSTP1—coronary artery disease	1.81e-06	4.2e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—AGT—coronary artery disease	1.81e-06	4.2e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—PPARG—coronary artery disease	1.81e-06	4.2e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	1.79e-06	4.16e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—HMOX1—coronary artery disease	1.79e-06	4.14e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—POMC—coronary artery disease	1.78e-06	4.14e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—ALB—coronary artery disease	1.78e-06	4.14e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—APOE—coronary artery disease	1.77e-06	4.12e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—CAT—coronary artery disease	1.76e-06	4.09e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—APOA1—coronary artery disease	1.75e-06	4.07e-05	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—PTGS2—coronary artery disease	1.74e-06	4.03e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—APOB—coronary artery disease	1.71e-06	3.97e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—NOS3—coronary artery disease	1.71e-06	3.96e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.68e-06	3.9e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—GSTM1—coronary artery disease	1.66e-06	3.86e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—LPL—coronary artery disease	1.63e-06	3.79e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—ALB—coronary artery disease	1.63e-06	3.77e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—GPX1—coronary artery disease	1.59e-06	3.7e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—PTGS2—coronary artery disease	1.56e-06	3.62e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—NOS3—coronary artery disease	1.56e-06	3.61e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—CD36—coronary artery disease	1.55e-06	3.6e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—PPARG—coronary artery disease	1.55e-06	3.59e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—PPP2CA—coronary artery disease	1.53e-06	3.56e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—POMC—coronary artery disease	1.52e-06	3.54e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—MTHFR—coronary artery disease	1.47e-06	3.41e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—PTGS2—coronary artery disease	1.42e-06	3.3e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—AGT—coronary artery disease	1.4e-06	3.24e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—ALB—coronary artery disease	1.39e-06	3.22e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—APOE—coronary artery disease	1.37e-06	3.18e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—APOA1—coronary artery disease	1.35e-06	3.14e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—NOS3—coronary artery disease	1.33e-06	3.08e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—PTGS2—coronary artery disease	1.22e-06	2.82e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—PPARG—coronary artery disease	1.19e-06	2.77e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—POMC—coronary artery disease	1.18e-06	2.73e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—ALB—coronary artery disease	1.07e-06	2.49e-05	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—PIK3CA—coronary artery disease	1.07e-06	2.48e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—NOS3—coronary artery disease	1.03e-06	2.38e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—PIK3CA—coronary artery disease	9.6e-07	2.23e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—PTGS2—coronary artery disease	9.38e-07	2.18e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—PIK3CA—coronary artery disease	8.75e-07	2.03e-05	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—AKT1—coronary artery disease	8.73e-07	2.03e-05	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—AKT1—coronary artery disease	7.84e-07	1.82e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—PIK3CA—coronary artery disease	7.48e-07	1.74e-05	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—AKT1—coronary artery disease	7.15e-07	1.66e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—AKT1—coronary artery disease	6.11e-07	1.42e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—PIK3CA—coronary artery disease	5.77e-07	1.34e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—AKT1—coronary artery disease	4.71e-07	1.09e-05	CbGpPWpGaD
